NO117910B - - Google Patents
Download PDFInfo
- Publication number
- NO117910B NO117910B NO158772A NO15877265A NO117910B NO 117910 B NO117910 B NO 117910B NO 158772 A NO158772 A NO 158772A NO 15877265 A NO15877265 A NO 15877265A NO 117910 B NO117910 B NO 117910B
- Authority
- NO
- Norway
- Prior art keywords
- urokinase
- solution
- dye salt
- acridine
- crude
- Prior art date
Links
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims description 29
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims description 29
- 229960005356 urokinase Drugs 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 11
- 239000000999 acridine dye Substances 0.000 claims description 7
- 239000000975 dye Substances 0.000 claims description 7
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 5
- 239000003463 adsorbent Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 2
- 238000005185 salting out Methods 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 15
- 210000002700 urine Anatomy 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 102000013566 Plasminogen Human genes 0.000 description 2
- 108010051456 Plasminogen Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- ZDXISBGMQLAJCD-UHFFFAOYSA-N 10-methyl-9H-acridine-3,6-diamine hydrochloride Chemical compound CN1C2=C(CC3=C1C=C(C=C3)N)C=CC(=C2)N.Cl ZDXISBGMQLAJCD-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 229940023020 acriflavine Drugs 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001026 thromboplastic effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/816—Enzyme separation or purification by solubility
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH861864A CH467075A (de) | 1964-07-01 | 1964-07-01 | Verfahren zur Gewinnung von Urokinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO117910B true NO117910B (en, 2012) | 1969-10-13 |
Family
ID=4342701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO158772A NO117910B (en, 2012) | 1964-07-01 | 1965-07-01 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3468760A (en, 2012) |
| BE (1) | BE665993A (en, 2012) |
| BR (1) | BR6570925D0 (en, 2012) |
| CH (1) | CH467075A (en, 2012) |
| DE (1) | DE1263659B (en, 2012) |
| DK (1) | DK108251C (en, 2012) |
| GB (1) | GB1044706A (en, 2012) |
| IL (1) | IL23823A (en, 2012) |
| NL (1) | NL6508350A (en, 2012) |
| NO (1) | NO117910B (en, 2012) |
| SE (1) | SE308902B (en, 2012) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3650903A (en) * | 1969-07-15 | 1972-03-21 | Rand Lab Inc | Method of production of fibrinolytic material |
| DE2308013A1 (de) * | 1973-02-17 | 1974-09-12 | Behringwerke Ag | Katalasearme glucoseoxidase und verfahren zu ihrer gewinnung |
| US4190573A (en) * | 1974-02-14 | 1980-02-26 | Behringwerke Aktiengesellschaft | Process for the isolation of the polyvalent proteinase inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL96631C (en, 2012) * | 1955-07-01 | |||
| US2961382A (en) * | 1957-07-25 | 1960-11-22 | Ortho Pharma Corp | Urokinase-a plasmiogen activator and methods of obtaining the same |
| US2989440A (en) * | 1959-01-23 | 1961-06-20 | Ortho Pharmacentical Corp | Urokinase-alpha plasminogen activator and methods of obtaining the same |
| US3355361A (en) * | 1964-10-15 | 1967-11-28 | Sterling Drug Inc | Recovery and purification of urokinase |
-
1964
- 1964-07-01 CH CH861864A patent/CH467075A/de unknown
-
1965
- 1965-06-24 GB GB26860/65A patent/GB1044706A/en not_active Expired
- 1965-06-25 US US467100A patent/US3468760A/en not_active Expired - Lifetime
- 1965-06-25 BE BE665993D patent/BE665993A/xx unknown
- 1965-06-25 DE DEP37138A patent/DE1263659B/de active Pending
- 1965-06-28 IL IL23823A patent/IL23823A/en unknown
- 1965-06-29 NL NL6508350A patent/NL6508350A/xx unknown
- 1965-06-30 DK DK332465AA patent/DK108251C/da active
- 1965-07-01 BR BR170925/65A patent/BR6570925D0/pt unknown
- 1965-07-01 NO NO158772A patent/NO117910B/no unknown
- 1965-07-01 SE SE8712/65A patent/SE308902B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK108251C (da) | 1967-10-30 |
| IL23823A (en) | 1969-03-27 |
| SE308902B (en, 2012) | 1969-03-03 |
| BE665993A (en, 2012) | 1965-10-18 |
| GB1044706A (en) | 1966-10-05 |
| US3468760A (en) | 1969-09-23 |
| CH467075A (de) | 1969-01-15 |
| NL6508350A (en, 2012) | 1966-01-03 |
| BR6570925D0 (pt) | 1973-08-02 |
| DE1263659B (de) | 1968-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102911290B (zh) | 从肝素副产物中分离提纯肝素钠和硫酸乙酰肝素的方法 | |
| GB1482237A (en) | Treatment of cooking oil | |
| CN103305492A (zh) | 一种高纯度医药级菠萝蛋白酶的提取方法 | |
| CN103012470A (zh) | 利用菜籽粕制备液体植酸的方法 | |
| CN103214597B (zh) | 依诺肝素钠中间体脱色方法 | |
| EP0010381B1 (en) | Regeneration of activated carbon | |
| CN113061199A (zh) | 一种纳滤膜浓缩提取粗品肝素钠的工艺 | |
| US3723251A (en) | Method for extracting urokinase | |
| NO117910B (en, 2012) | ||
| JPS60258123A (ja) | 第▲１０３▼因子標品の取得法ならびにその使用 | |
| CN1102067C (zh) | 一种从海带中提取活性碘的方法 | |
| GB1016150A (en) | Method of amylose purification | |
| US3069323A (en) | Insulin recovery process | |
| JP2631469B2 (ja) | ヒアルロン酸の精製法 | |
| CN114907498A (zh) | 一种提高树脂吸附酶解液中肝素钠的工艺 | |
| SU1028237A3 (ru) | Способ получени гепарина | |
| US4025390A (en) | Method for recovering urokinase from a urokinase-containing solution | |
| CN110330441B (zh) | 一种d-亮氨酸的提纯方法 | |
| CN110143868B (zh) | 一种柠檬酸钠母液除铁的方法 | |
| CN102584611A (zh) | 一种药用级缬氨酸的生产方法 | |
| JPS5973561A (ja) | 天然タウリンの製造方法 | |
| CN111171183A (zh) | 一种酶解方式提取肠衣肝素钠工艺 | |
| CN109280092A (zh) | 一种粗品肝素钠的提纯方法 | |
| US4072667A (en) | Process for recovering microbial cellular proteins | |
| SU810612A1 (ru) | Способ дехлорировани воды |